Clements PJ - Search Results

1

Early undifferentiated connective tissue disease: III. Outcome and prognostic indicators in early scleroderma (systemic sclerosis).

Bulpitt KJ, Clements PJ, Lachenbruch PA, Paulus HE, Peter JB, Agopian MS, Singer JZ, Steen VD, Clegg DO, Ziminski CM, Alarcon GS, Luggen ME, Polisson RP, Willkens RF, Reading JC, Williams HJ, Ward JR. Bulpitt KJ, et al. Among authors: clements pj. Ann Intern Med. 1993 Apr 15;118(8):602-9. doi: 10.7326/0003-4819-118-8-199304150-00005. Ann Intern Med. 1993. PMID: 8452326

2

Cardiac score. A semiquantitative measure of cardiac involvement that improves prediction of prognosis in systemic sclerosis.

Clements PJ, Lachenbruch PA, Furst DE, Paulus HE, Sterz MG. Clements PJ, et al. Arthritis Rheum. 1991 Nov;34(11):1371-80. doi: 10.1002/art.1780341105. Arthritis Rheum. 1991. PMID: 1835389

3

Management of systemic sclerosis--a review.

Ng SC, Clements PJ, Paulus HE. Ng SC, et al. Among authors: clements pj. Singapore Med J. 1990 Jun;31(3):269-72. Singapore Med J. 1990. PMID: 2203150 Review.

4

Prognostic importance of cardiac arrhythmias in systemic sclerosis.

Kostis JB, Seibold JR, Turkevich D, Masi AT, Grau RG, Medsger TA Jr, Steen VD, Clements PJ, Szydlo L, D'Angelo WA. Kostis JB, et al. Among authors: clements pj. Am J Med. 1988 Jun;84(6):1007-15. doi: 10.1016/0002-9343(88)90305-1. Am J Med. 1988. PMID: 3376974

5

Abnormalities of renal physiology in systemic sclerosis. A prospective study with 10-year followup.

Clements PJ, Lachenbruch PA, Furst DE, Maxwell M, Danovitch G, Paulus HE. Clements PJ, et al. Arthritis Rheum. 1994 Jan;37(1):67-74. doi: 10.1002/art.1780370110. Arthritis Rheum. 1994. PMID: 8129765

6

Elevated serum levels of soluble interleukin 2 receptor, interleukin 2 and neopterin in diffuse and limited scleroderma: effects of chlorambucil.

Clements PJ, Peter JB, Agopian MS, Telian NS, Furst DE. Clements PJ, et al. J Rheumatol. 1990 Jul;17(7):908-10. J Rheumatol. 1990. PMID: 2213757

7

Skin score. A semiquantitative measure of cutaneous involvement that improves prediction of prognosis in systemic sclerosis.

Clements PJ, Lachenbruch PA, Ng SC, Simmons M, Sterz M, Furst DE. Clements PJ, et al. Arthritis Rheum. 1990 Aug;33(8):1256-63. doi: 10.1002/art.1780330828. Arthritis Rheum. 1990. PMID: 2390128

8

Immunosuppression with chlorambucil, versus placebo, for scleroderma. Results of a three-year, parallel, randomized, double-blind study.

Furst DE, Clements PJ, Hillis S, Lachenbruch PA, Miller BL, Sterz MG, Paulus HE. Furst DE, et al. Among authors: clements pj. Arthritis Rheum. 1989 May;32(5):584-93. doi: 10.1002/anr.1780320512. Arthritis Rheum. 1989. PMID: 2655606 Clinical Trial.

9

Interrelationships between pulmonary and extrapulmonary involvement in systemic sclerosis. A longitudinal analysis.

Tashkin DP, Clements PJ, Wright RS, Gong H Jr, Simmons MS, Lachenbruch PA, Furst DE. Tashkin DP, et al. Among authors: clements pj. Chest. 1994 Feb;105(2):489-95. doi: 10.1378/chest.105.2.489. Chest. 1994. PMID: 8306752

10

Measurement of clinical change in progressive systemic sclerosis: a 1 year double-blind placebo-controlled trial of N-acetylcysteine.

Furst DE, Clements PJ, Harris R, Ross M, Levy J, Paulus HE. Furst DE, et al. Among authors: clements pj. Ann Rheum Dis. 1979 Aug;38(4):356-61. doi: 10.1136/ard.38.4.356. Ann Rheum Dis. 1979. PMID: 386962 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

198 results

Search Page

Filters